|
Generic Name : Nadroparin
Pronunciation : na-droe-PARE-in
Trade Name(s):
India- Cardioparin Vial, Fraxiparine Pf-Syringe, Fraxodi Pf-Syringe, Nadrohep 2850 Iu Pf-Syringe, Nadrohep 3800 Iu Pf-Syringe, Nadroparin Vial. International- Fraxiparine, Fraxiparine Forte. This medication is a low molecular weight heparin, prescribed for venous thromboembolism, pulmonary embolism and unstable angina. When it is not to be taken (Contraindications):
When it is to be taken : Unstable Angina: Adults: The dose is based on body weight. It is usually 86 anti-factor Xa International Units (IU) per kilogram (kg) (39.1 anti-factor Xa IU per pound) of body weight injected under the skin every twelve hours for six days. Venous thromboembolism and Pulmonary Embolism: Adults: The dose is usually 2850 anti-factor Xa IU injected under the skin once a day beginning two to four hours before surgery and continuing for at least seven days. How it should be taken : It comes as a solution for injection, to be administered by a healthcare provider under the skin. Special Instruction : * Caution should be exercised in patients undergoing epidural anesthesia, history of heparin-induced platelet defects, increased risk of bleeding, severe liver or kidney disease, any allergy, during pregnancy and breastfeeding. * Monitor signs of bleeding and potassium level in blood. Side Effects : Most Common- Injection site blood clot, bruising, pain at injection site, decrease in platelets, nosebleed and blood in urine/stool. *Avoid excess dosage. Storage Conditions : Store it at controlled room temperature (15-30°C). Do not freeze or refrigerate. |
![]() Comment & Contribute
![]()
![]() ![]() | ||


